31 results
The Strategic Advisory Group of Experts
(SAGE) on Immunization met on
8–10 October 2019. This report summarizes the discussions, conclusions and
recommendations.
The Strategic Advisory Group of Experts
(SAGE) on Immunization1
met on 2–4 April
2019. This report summarizes their discussions, conclusions and recommendations.
Immunization has proven the test of time as one of public health’s most cost effective interventions. In 2017, the number of children immunized – 116.2
million – was the highest ever reported....
The Strategic Advisory Group of Experts (SAGE) on Immunization was established by the Director-General of the World Health Organization in 1999 to provide guidance on the work of WHO. SAGE is the...
The Strategic Advisory Group of Experts (SAGE) on Immunization met on 23–25 October 2018. This report summarizes the discussions, conclusions and recommendations of the Group.
The Strategic Advisory Group of Experts (SAGE) on immunization met on 17–18 April 2018. This report summarizes the discussions, conclusions and recommendations.
The Strategic Advisory Group of Experts (SAGE) on Immunization met on 17–19 October 2017. This report summarizes the discussions, conclusions and recommendations.
The Strategic Advisory Group of Experts on immunization (SAGE)1 met on 25–27 April 2017. This report summarizes the discussions, conclusions and recommendations.
Measles, a vaccine-preventable illness, is one of the most infectious diseases known to man. In 2015, an estimated 134,200 measles deaths occurred globally. Rubella, also vaccine-preventable, is a...
In 2016, some progress was made towards the goals set out in the Global Vaccine Action Plan (GVAP). The year saw the fewest number of cases of wild poliovirus ever reported, and three more countries...
The purpose of this systematic review is to identify, describe and assess the potential effectiveness of strategies to respond to issues of vaccine hesitancy that have been implemented and evaluated...
The SAGE Working Group on Vaccine Hesitancy concluded that vaccine hesitancy refers to delay in acceptance or refusal of vaccination despite availability of vaccination services. Vaccine hesitancy is...
The phased withdrawal of oral polio vaccine (OPV) associated with the Polio Eradication and Endgame Strategic Plan 2013-2018 began with the synchronized global replacement of trivalent OPV (tOPV)...
Background: In 2013, the World Health Organization’s (WHO’s) Strategic Advisory Group of Experts (SAGE) recommended that all 126 countries using only oral polio vaccine (OPV) introduce at least 1...
Work on the revised strategy, “EYE” (Eliminate Yellow fever Epidemics), started in July 2016 during the Angola and DRC outbreaks. A meeting of partners in September 2016 brought together...
The Strategic Advisory Group of Experts (SAGE) on immunization met on 18-20 October
2016 in Geneva, Switzerland. At the mid-term of the Decade of Vaccines (DoV), SAGE reviewed the progress made...
The term vaccine hesitancy refers to delay in acceptance or refusal of vaccines despite the availability of vaccination services. Different factors influence vaccine hesitancy and these are...
In a recent study on ethics in humanitarian health care, respondents pointed out the need for ethical guidance on issues such as vaccination during emergency situations.3 The World Health...
Vaccine-serotype (VT) invasive pneumococcal disease (IPD) rates declined substantially following introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into national immunization programs....
Vaccine “hesitancy” is an emerging term in the literature and discourse on vaccine decision-making and determinants of vaccine acceptance. It recognizes a continuum between the domains of vaccine...
Disease eradication is an attractive public health goal. In addition to eliminating illnesses and deaths, eradication can lead to substantial cost savings. Eradication has been attempted for many...
The term vaccine hesitancy refers to delay in acceptance or refusal of vaccines despite the availability of vaccination services. Different factors influence vaccine hesitancy and these are...
This is the first WHO position paper on a malaria vaccine. It focuses primarily on the available evidence concerning the only candidate malaria vaccine to have received a positive regulatory...
The WHO Strategic Advisory Group of Experts (SAGE) on immunization recently published their conclusions from a systematic review of the ‘non-specific’ or ‘heterologous effects’ of vaccines,...
The Global Vaccine Action Plan (GVAP) sets ambitious but achievable goals, to save thousands of lives through vaccination in this Decade of Vaccines to 2020.
The Decade of Vaccines is not on...
The Strategic Advisory Group of Experts on immunization (SAGE) met on 20–22 October 2015. This report summarizes the discussions, conclusions and recommendations. For the malaria session, SAGE was...
This article presents the World Health Organizations (WHO) recommendations on the use of Japanese Encephalitis (JE) vaccines excerpted from the WHO position paper on Japanese Encephalitis vaccines...
The Strategic Group of Advisory Experts (SAGE) on immunization is an independent advisory committee with a mandate to advise the World Health Organization (WHO) on the development of vaccine and...
Introduction of inactivated polio vaccine is imminent and may encounter the challenges that face new vaccines especially vaccine hesitancy. The study evaluated factors that may contribute to...
Based on the concerns about vaccine hesitancy and its impact on vaccine uptake rates and the performance of national immunization programmes, the Strategic Advisory Group of Experts (SAGE) on...
Despite a wide array of safe and effective vaccines in use globally, with major impacts on health worldwide, the WHO Strategic Advisory Group of Experts (SAGE) on Immunization has been repeatedly...